Genome-wide association study identifies single-nucleotide polymorphism in KCNB1 associated with left ventricular mass in humans: The HyperGEN Study

BackgroundWe conducted a genome-wide association study (GWAS) and validation study for left ventricular (LV) mass in the Family Blood Pressure Program – HyperGEN population. LV mass is a sensitive predictor of cardiovascular mortality and morbidity in all genders, races, and ages. Polymorphisms of candidate genes in diverse pathways have been associated with LV mass. However, subsequent studies have often failed to replicate these associations. Genome-wide association studies have unprecedented power to identify potential genes with modest effects on left LV mass. We describe here a GWAS for LV mass in Caucasians using the Affymetrix GeneChip Human Mapping 100 k Set. Cases (N = 101) and controls (N = 101) were selected from extreme tails of the LV mass index distribution from 906 individuals in the HyperGEN study. Eleven of 12 promising (Q < 0.8) single-nucleotide polymorphisms (SNPs) from the genome-wide study were successfully genotyped using quantitative real time PCR in a validation study.ResultsDespite the relatively small sample, we identified 12 promising SNPs in the GWAS. Eleven SNPs were successfully genotyped in the validation study of 704 Caucasians and 1467 African Americans; 5 SNPs on chromosomes 5, 12, and 20 were significantly (P ≤ 0.05) associated with LV mass after correction for multiple testing. One SNP (rs756529) is intragenic within KCNB1, which is dephosphorylated by calcineurin, a previously reported candidate gene for LV hypertrophy within this population.ConclusionThese findings suggest KCNB1 may be involved in the development of LV hypertrophy in humans.

[1]  N Risch,et al.  The Future of Genetic Studies of Complex Human Diseases , 1996, Science.

[2]  J. Laragh,et al.  Standardization of M-mode echocardiographic left ventricular anatomic measurements. , 1984, Journal of the American College of Cardiology.

[3]  D E Manyari,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[4]  Daniel L. McGee,et al.  Left ventricular hypertrophy has a greater impact on survival in women than in men. , 1995, Circulation.

[5]  B. Brenner,et al.  Hypertension: Pathophysiology, Diagnosis, and Management , 1994 .

[6]  J. Staessen,et al.  Ambulatory blood pressure and left ventricular structure and function in relation to the G-protein β3-subunit polymorphism C825T in White Europeans , 2003, Journal of Human Hypertension.

[7]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[8]  John D. Storey.  The positive false discovery rate: a Bayesian interpretation and the q-value , 2003 .

[9]  M A Province,et al.  NHLBI family blood pressure program: methodology and recruitment in the HyperGEN network. Hypertension genetic epidemiology network. , 2000, Annals of epidemiology.

[10]  S. P. Fodor,et al.  Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays , 2004, Nature Methods.

[11]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .

[12]  Michael R. Johnson,et al.  Heritability of left ventricular mass in a large cohort of twins , 2006, Journal of hypertension.

[13]  D. Levy,et al.  Heritability of left ventricular mass: the Framingham Heart Study. , 1997, Hypertension.

[14]  D. Levy,et al.  Association of echocardiographic left ventricular mass with body size, blood pressure and physical activity (the Framingham Study). , 1990, The American journal of cardiology.

[15]  J. Laragh,et al.  Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. , 1986, Annals of internal medicine.

[16]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  C. Semsarian,et al.  Progression of left ventricular hypertrophy and the angiotensin-converting enzyme gene polymorphism in hypertrophic cardiomyopathy. , 2004, International journal of cardiology.

[18]  T. Pasierski,et al.  Plasma neuropeptide Y immunoreactivity influences left ventricular mass in pheochromocytoma. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[19]  S. Daniels,et al.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. , 1992, Journal of the American College of Cardiology.

[20]  J. Molkentin.  Calcineurin and beyond: cardiac hypertrophic signaling. , 2000, Circulation research.

[21]  D. Rao,et al.  Novel genetic variants contributing to left ventricular hypertrophy: the HyperGEN study , 2009, Journal of hypertension.

[22]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[23]  M. Province,et al.  Identification of a novel 5-base pair deletion in calcineurin B (PPP3R1) promoter region and its association with left ventricular hypertrophy. , 2005, American heart journal.

[24]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.

[25]  L. Tiret,et al.  Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. , 1996, The New England journal of medicine.

[26]  D. Levy,et al.  Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study , 2007, BMC Medical Genetics.

[27]  H. S. Klopfenstein,et al.  M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). , 2001, The American journal of cardiology.

[28]  Gonçalo R. Abecasis,et al.  PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data , 2005, Bioinform..

[29]  R. Devereux,et al.  Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement. , 1999, Journal of the American College of Cardiology.

[30]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[31]  B. Müller-Myhsok,et al.  Quantitative trait loci for blood pressure exist near the IGF-1, the Liddle syndrome, the angiotensin II-receptor gene and the renin loci in man. , 1999, Journal of the American Society of Nephrology : JASN.

[32]  P. Palatini,et al.  G protein β3 subunit gene 825T allele is associated with increased left ventricular mass in young subjects with mild hypertension , 2001 .

[33]  L. Almasy,et al.  Heritability of left ventricular dimensions and mass in American Indians: The Strong Heart Study , 2004, Journal of hypertension.

[34]  Yuling Hong,et al.  Sibling correlation of left ventricular mass and geometry in hypertensive African Americans and whites: the HyperGEN study. Hypertension Genetic Epidemiology Network. , 2001, American journal of hypertension.